BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
14.66
-0.25 (-1.68%)
Sep 26, 2025, 4:00 PM EDT - Market closed
BrainsWay Employees
BrainsWay had 120 employees as of December 31, 2024. The number of employees decreased by 14 or -10.45% compared to the previous year.
Employees
120
Change (1Y)
-14
Growth (1Y)
-10.45%
Revenue / Employee
$384,033
Profits / Employee
$44,533
Market Cap
278.50M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BWAY News
- 5 weeks ago - BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd. - GlobeNewsWire
- 5 weeks ago - BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health - GlobeNewsWire
- 6 weeks ago - BrainsWay Ltd. (BWAY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights - GlobeNewsWire
- 3 months ago - BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD) - GlobeNewsWire
- 3 months ago - BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego - GlobeNewsWire
- 4 months ago - BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC - GlobeNewsWire
- 4 months ago - BrainsWay Ltd. (BWAY) Q1 2025 Earnings Call Transcript - Seeking Alpha